Publications by authors named "Andreas D Meid"

Claim this Profile
T
Testing Higher Doses of Sildenafil to Repair Brain Injury Secondary to Birth Asphyxia: An Open-Label Dose-Finding Phase 1b Clinical Trial-Sildenafil Administration to Treat Neonatal Encephalopathy-Study 02.
Pia Wintermark, Anie Lapointe, Gabriel Altit, Robin Steinhorn, Emmanouil Rampakakis, Andreas D Meid

J Pediatr· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of Arginine-Rich Cyclic Cell-Penetrating Peptide-Lipid Conjugates Using a Surrogate Peptide Extracted by Phospholipase D Digestion and Trifluoroacetic Acid-Based UPLC-MS/MS Analysis.
Cindy Bay, Philipp Uhl, Andreas D Meid, Jürgen Burhenne, Walter E Haefeli

Anal Chem· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting potassium trajectories for risk monitoring in outpatients with heart failure, diabetes mellitus or chronic kidney disease.
Camilo Scherkl, Jacob Grytzka, Marietta Rottenkolber, Tobias Dreischulte, Hanna M Seidling, Andreas D Meid

Br J Clin Pharmacol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards a prescribing monitoring system for medication safety evaluation within electronic health records: a scoping review.
Camilo Scherkl, Theresa Dierkes, Michael Metzner, David Czock, Hanna M Seidling, Andreas D Meid

BMC Med Inform Decis Mak· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transporting trial results to synthetic real-world populations in order to estimate real-world effectiveness of newly marketed medicines.
Ignacio Leiva-Escobar, Camilo Scherkl, Walter E Haefeli, Andreas D Meid

BMJ Open· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of a Short Course of Ritonavir Used as Booster in Antiviral Therapies Against SARS-CoV-2 on the Exposure of Atorvastatin and Rosuvastatin.
Evelyn Krohmer, Brit Silja Rohr, Felicitas Stoll, Katja S Gümüs, Mariano Bergamino, Andreas D Meid

Cardiovasc Drugs Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the frequently used antiepileptic drugs carbamazepine, gabapentin, and pregabalin on the pharmacokinetics of edoxaban and other oral factor xa inhibitors in healthy volunteers.
Alexander Lenard, Simon A Hermann, Felicitas Stoll, Juergen Burhenne, Kathrin I Foerster, Andreas D Meid

Front Pharmacol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypes of Patients with Direct Oral Anticoagulant (DOAC) Underdosing in Atrial Fibrillation: Results from the ARENA Registry.
Christine Brockmüller, Andreas D Meid, Jochen Senges, Matthias Hochadel, Walter E Haefeli

Clin Drug Investig· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Clarithromycin, a Strong CYP3A and P-glycoprotein Inhibitor, on the Pharmacokinetics of Edoxaban in Healthy Volunteers and the Evaluation of the Drug Interaction with Other Oral Factor Xa Inhibitors by a Microdose Cocktail Approach.
Alexander Lenard, Simon A Hermann, Felicitas Stoll, Juergen Burhenne, Kathrin I Foerster, Andreas D Meid

Cardiovasc Drugs Ther· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Quality of medication documentation in patientś discharge summaries after implementing new legal requirements].
Sophia Klasing, Viktoria Jungreithmayr, Benedict Morath, Camilo Scherkl, Andreas D Meid

Z Evid Fortbild Qual Gesundhwes· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Application of a Quantitative Systems Pharmacology (QSP) Model to Predict Potassium Concentrations from Electronic Health Records: A Pilot Case towards Prescribing Monitoring of Spironolactone.
Andreas D Meid, Camilo Scherkl, Michael Metzner, David Czock, Hanna M Seidling

Pharmaceuticals (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying Predictors of Heart Failure Readmission in Patients From a Statutory Health Insurance Database: Retrospective Machine Learning Study.
Rebecca T Levinson, Cinara Paul, Andreas D Meid, Jobst-Hendrik Schultz, Beate Wild

JMIR Cardio· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coadministration of fluconazole to boost subtherapeutic sirolimus concentrations: A case report.
Camilo Scherkl, Andreas D Meid, Sven E Cuntz, Laura Classen, Johanna Weiss

Pharmacol Res Perspect· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Event Analysis for Automated Estimation of Absent and Persistent Medication Alerts: Novel Methodology.
Janina A Bittmann, Camilo Scherkl, Andreas D Meid, Walter E Haefeli, Hanna M Seidling

JMIR Med Inform· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and Safety of Sildenafil to Repair Brain Injury Secondary to Birth Asphyxia (SANE-01): A Randomized, Double-blind, Placebo-controlled Phase Ib Clinical Trial.
Pia Wintermark, Anie Lapointe, Robin Steinhorn, Emmanouil Rampakakis, Jürgen Burhenne, Andreas D Meid

J Pediatr· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Tacrolimus Formulation (Prolonged-Release vs Immediate-Release) on Its Susceptibility to Drug-Drug Interactions with St. John's Wort.
Katja S Gümüs, Anna Teegelbekkers, Max Sauter, Andreas D Meid, Jürgen Burhenne

Clin Pharmacol Drug Dev· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proceedings of the International Ambulatory Drug Safety Symposium: Munich, Germany, June 2023.
G Caleb Alexander, Daniel Budnitz, Carmel Hughes, Renke Maas, Alpana Mair, Andreas D Meid

Drug Saf· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYP3A and CYP2C19 Activity Determined by Microdosed Probe Drugs Accurately Predict Voriconazole Clearance in Healthy Adults.
Amin Muhareb, Antje Blank, Andreas D Meid, Kathrin I Foerster, Felicitas Stoll

Clin Pharmacokinet· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physiology-based pharmacokinetic modelling and experimental data suggest that rifabutin alters dolutegravir kinetics by both P-glycoprotein induction and concurrent inhibition.
Dirk Theile, Julie Nilles, Andreas D Meid

Br J Clin Pharmacol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysing and improving preoperative medication management in cardiac surgery.
Benedict Morath, Andreas D Meid, Marcin Zaradzki, Carolin Geßele, Stefanie Nüse

Br J Clin Pharmacol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mortality and Hospitalizations Among Patients Enrolled in an Interprofessional Medication Management Program.
Andreas D Meid, Lucas Wirbka, Robert Moecker, Carmen Ruff, Marina Weissenborn

Dtsch Arztebl Int· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticholinergic burden measures, symptoms, and fall-associated risk in older adults with polypharmacy: Development and validation of a prognostic model.
Truc Sophia Dinh, Andreas D Meid, Henrik Rudolf, Maria-Sophie Brueckle, Ana I González-González

PLoS One· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of the Time Course of CYP3A Inhibition, Activation, and Induction Using a Population Pharmacokinetic Model of Microdosed Midazolam Continuous Infusion.
Yomna M Nassar, Nicolas Hohmann, Robin Michelet, Katharina Gottwalt, Andreas D Meid

Clin Pharmacokinet· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prediction model for nonpersistence or nonadherence to direct oral anticoagulants in hospitalized patients with atrial fibrillation.
Lucas Wirbka, Carmen Ruff, Walter E Haefeli, Andreas D Meid

J Manag Care Spec Pharm· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIOPP-6 - a pilot study on the evaluation of an electronic tool to assess and reduce the complexity of drug treatment considering patients' views.
Viktoria S Wurmbach, Steffen J Schmidt, Anette Lampert, Simone Bernard, Andreas D Meid

BMC Prim Care· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis